Alopecia Secondary to Mesotherapy

    Bruna Duque‐Estrada, Colombina Vincenzi, Cosimo Misciali, Antonella Tosti
    Image of study
    TLDR Some people experienced hair loss after mesotherapy treatments for hair loss.
    The document described two cases where individuals developed alopecia following mesotherapy treatments for androgenetic alopecia. A 32-year-old woman experienced patchy hair loss and sustained a small area of permanent cicatricial alopecia three months post-treatment after receiving injections of mesoglycan. Another 22-year-old woman suffered from reversible hair loss after being treated with homeopathic injections. These cases underscore the potential adverse effects of mesotherapy, such as acute and cicatricial alopecia, and call attention to the necessity for caution due to insufficient controlled studies on the safety and effectiveness of this treatment for hair loss.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community Totally confused by doctors opinions, would appreciate some clarity

      in Treatment  1 upvotes 2 weeks ago
      The user is experiencing hair loss and confusion over conflicting medical advice, with treatments including minoxidil, finasteride, and topical corticosteroids. They are unsure about the necessity of a biopsy and the timing of using minoxidil, while also considering the impact of potential androgenetic alopecia and telogen effluvium.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Bryan Johnson’s Hairloss Regimine

      in Research/Science  27 upvotes 1 year ago
      The post is about Bryan Johnson's hair loss regimen, which includes dutasteride mesotherapy, minoxidil, microneedling, and red laser therapy. The conversation includes discussions about the effectiveness of topical dutasteride and speculation about whether Bryan Johnson has had a hair transplant.

    Similar Research

    5 / 1000+ results
      Alopecia Areata: An Update

      research Alopecia Areata: An Update

      67 citations, January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.
      Mesotherapy: Myth and Reality

      research Mesotherapy: Myth and Reality

      3 citations, April 2011 in “Expert Review of Dermatology”
      Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.
      Mesotherapy: What Is New?

      research Mesotherapy: What Is New?

      34 citations, December 2012 in “Indian Journal of Dermatology, Venereology and Leprology”
      Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.